The President of United States has enacted Ensuring Compliance against Drug Diversion Act, 2021 on November 10, 2021 which amends the Controlled Substances Act to provide statutory authority for the modification, transfer, and termination of a registration to manufacture, distribute, or dispense controlled substances. The modification, transfer and termination of registration would take place in following circumstances:
- If the registrant dies or ceases legal existence or discontinues business or professional practice or surrenders such registration.
- If a registrant ceases legal existence or discontinues business or professional practice, such registrant shall promptly notify the Attorney General in writing of such fact.
- In the case of a registrant under this title to manufacture, distribute, or dispense controlled substances or list I chemicals desiring to discontinue business or professional practice altogether or with respect to controlled substances and list I chemicals (without assigning or transferring such business or professional practice to another entity), such registrant shall return to the Attorney General for cancellation—
- the registrant’s certificate of registration
- any unexecuted order forms in the registrant’s possession and
- any other documentation that the Attorney General may require.
